Abstract
Purpose
The occurrence of cardiac pacemaker pocket infection has markedly increased and has become a new problem facing cardiovascular internists. The aim of our study was to investigate the effectiveness and safety of treating cardiac pacemaker pocket infection using negative-pressure wound therapy (NPWT) in patients who are unwilling or unable to have their cardiac implantable electronic devices (CIEDs) removed.
Methods
From March 2013 to April 2019, NPWT was applied to 26 patients with cardiac pacemaker pocket infection who were unwilling or unable to have their CIEDs removed. In the first stage, a negative-pressure drainage system was placed in the pacemaker pocket after debridement. Then, NPWT was used to seal the wound, and the negative pressure (300–400 mmHg) was sustained for 5–7 days. In the second stage, the pacemaker was relocated to the subpectoral layer, and the wound was closed.
Results
In all but three of our 26 patients, the wound healed completely without complications and without evidence of residual infection. The average follow-up period was 26.92 ± 9.46 months. Only 3 diabetic patients whose tissue bacterial cultures revealed that methicillin-resistant Staphylococcus epidermidis developed uncontrolled infections. Eventually, the entire original pacemaker systems were removed, and new pacemakers were implanted in the contralateral chest wall.
Conclusions
When warranted by strictly selected indications, the method of NPWT without CIED extraction can be considered as a new and effective treatment for patients with pacemaker pocket infection who are unwilling or unable to have the device removed.
Similar content being viewed by others
Data availability
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
References
Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–77.
Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001–6.
Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6(7):1085–104.
Harrison JL, Prendergast BD, Sandoe JA. Guidelines for the diagnosis, management and prevention of implantable cardiac electronic device infection. Heart. 2015;101(4):250–2.
Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116(12):1349–55.
Smith MC, Love CJ. Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol. 2008;31(6):736–52.
Ipek EG, Guray U, Demirkan B, Guray Y, Aksu T. Infections of implantable cardiac rhythm devices: predisposing factors and outcome. Acta Cardiol. 2012;67(3):303–10.
Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, et al. Contemporary management of and outcomes from cardiac device related infections. Europace. 2010;12(1):64–70.
Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. Jama. 2012;307(16):1727–35.
Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70(2):325–59.
Traykov V, Bongiorni MG, Boriani G, Burri H, Costa R, Dagres N, et al. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association. Europace. 2019.
Fleck T, Fleck M. Negative pressure wound therapy for the treatment of sternal wound infections after cardiac surgery. Int Wound J. 2014;11(3):240–5.
Kanakaris NK, Thanasas C, Keramaris N, Kontakis G, Granick MS, Giannoudis PV. The efficacy of negative pressure wound therapy in the management of lower extremity trauma: review of clinical evidence. Injury. 2007;38(Suppl 5):S9–18.
Petzina R, Hoffmann J, Navasardyan A, Malmsjo M, Stamm C, Unbehaun A, et al. Negative pressure wound therapy for post-sternotomy mediastinitis reduces mortality rate and sternal re-infection rate compared to conventional treatment. Eur J Cardiothorac Surg. 2010;38(1):110–3.
McGarry TJ, Joshi R, Kawata H, Patel J, Feld G, Birgersdotter-Green UM, et al. Pocket infections of cardiac implantable electronic devices treated by negative pressure wound therapy. Europace. 2014;16(3):372–7.
Poller WC, Schwerg M, Melzer C. Therapy of cardiac device pocket infections with vacuum-assisted wound closure-long-term follow-up. Pacing Clin Electrophysiol. 2012;35(10):1217–21.
Dy Chua J, Abdul-Karim A, Mawhorter S, Procop GW, Tchou P, Niebauer M, et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol. 2005;28(12):1276–81.
Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147(4):582–6.
Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33(4):414–9.
Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.
Wazni O, Wilkoff BL. Considerations for cardiac device lead extraction. Nat Rev Cardiol. 2016;13(4):221–9.
Zhou X, Jiang H, Ma J, Bakhai A, Li J, Zhang Y, et al. Comparison of standard and modified transvenous techniques for complex pacemaker lead extractions in the context of cardiac implantable electronic device-related infections: a 10-year experience. Europace. 2013;15(11):1629–35.
Klug D, Wallet F, Lacroix D, Marquie C, Kouakam C, Kacet S, et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart. 2004;90(8):882–6.
Satsu T, Onoe M. Vacuum-assisted wound closure for pacemaker infection. Pacing and clinical electrophysiology. 2010;33(4):426–30.
Puri R, Psaltis PJ, Nelson AJ, Sanders P, Young GD. Povidone-iodine irrigation-a possible alternative to lead extraction. Indian Pacing Electrophysiol J. 2011;11(4):115–9.
Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm. 2010;7(8):1043–7.
Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997;38(6):553–62.
Morykwas MJ, Simpson J, Punger K, Argenta A, Kremers L, Argenta J. Vacuum-assisted closure: state of basic research and physiologic foundation. Plast Reconstr Surg. 2006;117(7 Suppl):121S–6S.
Saxena V, Hwang CW, Huang S, Eichbaum Q, Ingber D, Orgill DP. Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg. 2004;114(5):1086–96 discussion 97-8.
Wang J, Zhang H, Wang S. Application of vacuum sealing drainage in the treatment of internal fixation instrument exposure after early postoperative infection. Minerva Chir. 2015;70(1):17–22.
Pawar DRL, Mitchell SJ, Jeyapalina S, Hawkes JE, Florell SR, Bachus KN. Peri-prosthetic tissue reaction to discontinuation of negative pressure wound therapy around porous titanium percutaneous devices. J Biomed Mater Res B Appl Biomater. 2018.
Santarpino G, Gazdag L, Sirch J, Vogt F, Ledwon M, Fischlein T, et al. A retrospective study to evaluate use of negative pressure wound therapy in patients undergoing bilateral internal thoracic artery grafting. Ostomy Wound Manage. 2015;61(12):26–30.
Copeland H, Newcombe J, Yamin F, Bhajri K, Mille VA, Hasaniya N, et al. Role of negative pressure wound care and hyperbaric oxygen therapy for sternal wound infections after pediatric cardiac surgery. World J Pediatr Congenit Heart Surg. 2018;9(4):440–5.
Petit-Clair N, Smith M, Chernev I. Modified NPWT using round channel drain for pacemaker pocket non-healing complex wound: a case report.pdf. J Wound Care. 2014;23(9):453–5.
Thomas S, Nicolas D, Christopher P, Sebastian H, Friedrich WM. Vacuum-assisted treatment of severe pacemaker pocket infection. Herzschrittmacherther Elektrophysiol. 2008;19(4):181–4.
Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, et al. Role of (18)F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis. J Nucl Cardiol. 2019;26(3):958–70.
Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2017;10(4).
Sollini M, Berchiolli R, Delgado Bolton RC, Rossi A, Kirienko M, Boni R, et al. The “3M” approach to cardiovascular infections: multimodality, multitracers, and multidisciplinary. Semin Nucl Med. 2018;48(3):199–224.
Code availability
Not applicable.
Author information
Authors and Affiliations
Contributions
Conceptualization: Shengwu Zheng and Xiongmei Huang; methodology: Shengwu Zheng; formal analysis and investigation: Yazhou Lin, Xiaohui Chen, Genhui Lin, and Jing Zhuang; writing–original draft preparation: Xiongmei Huang; writing–review and editing: Shengwu Zheng and Xiaohui Chen; resources: Shengwu Zheng and Xiongmei Huang; supervision: Shengwu Zheng.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Fujian Provincial Hospital (No. K2013-02-002).
Consent to participate
Informed consent was obtained from the patients prior to study participation.
Consent for publication
Patients signed informed consent regarding publishing their data and photographs.
Open access
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zheng, S., Huang, X., Lin, Y. et al. Negative-pressure wound therapy (NPWT) for the treatment of pacemaker pocket infection in patients unable or unwilling to undergo CIED extraction. J Interv Card Electrophysiol 61, 245–251 (2021). https://doi.org/10.1007/s10840-020-00805-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-020-00805-y